Northwestern surgeons perform double lung transplant in 2 cancer patients

Northwestern Medicine is pioneering a new treatment for stage 4 cancer patients: double lung transplants.

Advertisement

Surgeons at the Chicago-based health system have successfully performed two such transplants on patients who were previously being considered for hospice. Now, the system is launching a new clinical program to offer the treatment to other patients whose cancer has spread to both lungs but not other parts of the body. 

Researchers will also track the outcomes of the clinical program’s first 75 patients through a new research registry.

Surgeons conducted the first double lung transplant on Chicago resident Albert Khoury in September 2021. Tannaz Ameli, a retired nurse from Minnesota, underwent her transplant in July 2022. Neither patient required additional cancer treatments after the transplant. 

The medical advancements build upon Northwestern’s research on COVID-19 lung transplantation. In 2020, the health system became the first in the U.S. to complete a double lung transplant on a COVID-19 patient. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Patient Safety & Outcomes

Advertisement

Comments are closed.